pharmaphorum
AUGUST 13, 2020
How the COVID-19 pandemic is forging pharmaceutical brands into better shape. Day by day it becomes clearer that some brands are coming through the pandemic in better shape than ever. These are the brands that have clearly demonstrated emotional intelligence, that have shown emotional empathy to their target audience.
XTalks
SEPTEMBER 3, 2021
The company’s new brand identity includes a new website, curiaglobal.com , that features the tagline, “From curiosity to cure” that plays on the Curia name. In its early days, it became best known for the discovery and development of the active ingredient in the allergy medication Allegra.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JULY 28, 2022
That could propel the Regeneron-partnered drug into the top five biggest sellers, behind massive brands like AbbVie’s immunology blockbuster Humira (adalimumab), Merck & Co’s cancer immunotherapy Keytruda (pembrolizumab) and COVID-19 vaccines. Vaccine sales climbed 15% to €1.8
XTalks
MAY 2, 2024
Among these are Madrigal Pharmaceuticals’ resmetirom (branded Rezdiffra) , which secured FDA approval in March for the treatment of nonalcoholic steatohepatitis (NASH) and sotatercept (commercial name Winrevair) for pulmonary hypertension (PAH). The condition is an adverse event linked to competitor vaccines. percent to 77.8
pharmaphorum
SEPTEMBER 29, 2022
Sanofi and Regeneron have predicted that Dupixent could make around $13 billion a year at peak, which would propel the drug into the top five biggest pharmaceutical sellers behind brands like AbbVie’s immunology blockbuster Humira (adalimumab), Merck & Co’s cancer immunotherapy Keytruda (pembrolizumab), and COVID-19 vaccines.
The Pharma Data
DECEMBER 30, 2020
AstraZeneca Dives into Rare Diseases: AstraZeneca has been in the spotlight for the COVID-19 vaccine candidate it developed with Oxford University. The company has a number of branded products in this space, including Soliris (eculizumab), a first-in-class anti-complement component 5 (C5) monoclonal antibody. But the U.K.-based
XTalks
DECEMBER 20, 2023
report indicating that they accounted for half of the most viewed new brands. Bayer’s Astepro (azelastine), an over-the-counter medication for cold, flu and allergies, led the pack in the first half of 2023 with 7.4 Notably, pharmaceutical drugs dominated TV ad impressions this year, with an iSpot.tv billion ad impressions.
Expert insights. Personalized for you.
90 
Let's personalize your content